Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalai nagar, Tamil Nadu, India.
Eur J Pharmacol. 2011 May 11;658(2-3):206-12. doi: 10.1016/j.ejphar.2011.02.031. Epub 2011 Mar 1.
The present study was aimed to evaluate the radioprotective efficacy of hesperidin, a flavonone glycoside against X-ray radiation-induced cellular damage in the liver of Swiss albino mice. The first phase of the study was carried out to fix the effective concentration of hesperidin by performing a 30 days of survival studies using different graded doses [12.5, 25, 50 and 100mg/kg body weight] of hesperidin administered orally to mice via intragastric intubations for seven consecutive days prior to exposure of whole body radiation (10 Gy). Based on the results of survival studies, the effective dose of hesperidin was fixed which was then administered to animals orally via intragastric intubations for seven consecutive days prior to exposure of whole body radiation (4 Gy) to evaluate its radioprotective efficacy by performing various biochemical estimations, comet assay, DNA fragmentation assay and histopathological studies in the liver of Swiss albino mice. The results indicated that radiation-induced decrease in the levels of endogenous antioxidant enzymes and increase in lipid peroxidative index, DNA damage and comet parameters were altered by pre-administration with the effective dose of hesperidin [25mg/kg body weight] which restored the antioxidant status to near normal and decreased the levels of lipid peroxidative index, DNA damage and comet parameters. These results were further confirmed by histopathological examinations which indicated that pre-administration with the effective dose of hesperidin reduced the hepatic damage induced by radiation. Thus the current study shows hesperidin to be an effective radioprotector against radiation induced damage in the liver of mice.
本研究旨在评估橙皮苷(一种类黄酮糖苷)对 X 射线辐射诱导的瑞士白化小鼠肝脏细胞损伤的放射防护作用。研究的第一阶段通过进行 30 天的生存研究来固定橙皮苷的有效浓度,使用不同分级剂量[12.5、25、50 和 100mg/kg 体重]的橙皮苷通过胃内插管口服给予小鼠,在全身辐射(10Gy)暴露前连续 7 天。基于生存研究的结果,固定了橙皮苷的有效剂量,然后在全身辐射(4Gy)暴露前通过胃内插管连续 7 天口服给予动物,以通过各种生化测定、彗星试验、DNA 片段化试验和瑞士白化小鼠肝脏的组织病理学研究来评估其放射防护作用。结果表明,辐射诱导的内源性抗氧化酶水平降低和脂质过氧化指数、DNA 损伤和彗星参数增加,通过预先给予有效剂量的橙皮苷[25mg/kg 体重]得到改变,该剂量将抗氧化状态恢复到接近正常水平,并降低了脂质过氧化指数、DNA 损伤和彗星参数的水平。这些结果通过组织病理学检查得到进一步证实,表明预先给予有效剂量的橙皮苷可减少辐射引起的肝损伤。因此,本研究表明橙皮苷是一种有效的放射防护剂,可防止小鼠肝脏受到辐射损伤。